Showing results (1-10 of 57) with videos related to

Sort By:
Pageof 6
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|November 3, 2022
[Development of Novel Dosing Strategy According to the Area under the Concentration-Time Curve for Vancomycin]Kazutaka Oda
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|June 10, 2026
Effect of body composition on initial teicoplanin dosing and optimization of the regimenShoji Kondo, Kazutaka Oda, Hirofumi Jono
Respiratory Care|February 17, 2021
Prediction of Apnea Testing Duration to Ensure Safety During Brain Death AssessmentKatsuyuki Sagishima, Kazutaka Oda, Yoshihiro Kinoshita
Pharmacology & Therapeutics|May 6, 2023
Bayesian prediction-based individualized dosing of anti-methicillin-resistant Staphylococcus aureus treatment: Recent advancements and prospects in therapeutic drug monitoringKazutaka Oda, Hideyuki Saito, Hirofumi Jono
Therapeutic Drug Monitoring|July 1, 2024
Optimizing Cefiderocol Dosing Through Population Pharmacokinetic/Pharmacodynamic Simulation: An Assessment of Drug Cost ReductionsKazutaka Oda, Hirofumi Jono, Hideyuki Saito
Antimicrobial Agents and Chemotherapy|May 17, 2023
Model-Informed Precision Dosing of Vancomycin in Adult Patients Undergoing HemodialysisKazutaka Oda, Hirofumi Jono, Hideyuki Saito
European Journal of Hospital Pharmacy : Science and Practice|October 17, 2025
Incidence of hypokalaemia in tazobactam/piperacillin-treated patients and identification of risk factors: a retrospective observational studyKazutaka Uchida, Kenshiro Higashi, Yoshihiro Nakagawa, et al.
Basic & Clinical Pharmacology & Toxicology|November 27, 2024
Limited sampling approach for model-informed precision dosing of daptomycin to rapidly achieving the target area under the concentration-time curve: A simulation studyTomoyuki Yamada, Kazutaka Oda, Masami Nishihara, et al.
International Journal of Antimicrobial Agents|July 30, 2020
Reduced nephrotoxicity with vancomycin therapeutic drug monitoring guided by area under the concentration-time curve against a trough 15-20 μg/mL concentrationKazutaka Oda, Hirofumi Jono, Kisato Nosaka, et al.
Therapeutic Drug Monitoring|May 17, 2024
Population Pharmacokinetic Modeling of Unbound Meropenem in Patients Undergoing Continuous Renal Replacement Therapy: An Observational Cohort StudyKazutaka Oda, Hirofumi Jono, Hidenobu Kamohara, et al.
Pageof 6